Intimation of Closure of Trading Window of Jenburkt Pharmaceuticals Limited as per the SEBI (Prohibition of Insider Trading) Regulations, 2015.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Jenburkt Pharmaceuticals has informed the BSE that its trading window for equity shares will be closed from 1st October 2025 until 48 hours after the company's standalone unaudited financial results for the quarter and half year ending 30th September 2025 are made public. The closure applies to all designated persons, insiders, and their connected persons and relatives, as required under the SEBI (Prohibition of Insider Trading) Regulations, 2015. The company will separately announce the date of the board meeting that will consider and approve these quarterly and half-yearly results. The intimation was signed by Ashish R. Shah, Company Secretary and Compliance Officer.
This is a routine compliance filing that signals Q2 FY26 and H1 FY26 results are likely to be announced in the near term. It has no direct impact on the stock price but indicates upcoming earnings disclosure.